Cargando…
Efficacy of repeated intravenous esketamine in adolescents with anxious versus non-anxious depression
BACKGROUND: Patients with anxious major depressive disorder (MDD) are more likely to have poorer outcomes than those with non-anxious MDD. However, the effect of esketamine on adolescents with anxious versus non-anxious MDD has remained unknown. AIMS: We compared the efficacy of esketamine in adoles...
Autores principales: | Lan, Xiaofeng, Wang, Chengyu, Zhang, Fan, Liu, Haiyan, Fu, Ling, Li, Weicheng, Ye, Yanxiang, Hu, Zhibo, Mai, Siming, Ning, Yuping, Zhou, Yanling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314616/ https://www.ncbi.nlm.nih.gov/pubmed/37396782 http://dx.doi.org/10.1136/gpsych-2023-101007 |
Ejemplares similares
-
Short-term cognitive effects of repeated-dose esketamine in adolescents with major depressive disorder and suicidal ideation: a randomized controlled trial
por: Lan, Xiaofeng, et al.
Publicado: (2023) -
The efficacy and safety of esketamine in the treatment of major depressive disorder with suicidal ideation: study protocol for a randomized controlled trial
por: Liu, Haiyan, et al.
Publicado: (2022) -
Functional connectivity of the amygdala and the antidepressant and antisuicidal effects of repeated ketamine infusions in major depressive disorder
por: Liu, Haiyan, et al.
Publicado: (2023) -
Anxious or Depressed and Still Happy?
por: Spinhoven, Philip, et al.
Publicado: (2015) -
Are there anxious genes?
por: Morris-Rosendahl, Deborah J.
Publicado: (2002)